13F-HR filed by Consonance Capital Management LP
Consonance Capital Management LP filed this 13F-HR for the quarter ended 2016-12-31, filed 2017-02-14, with 23 holding rows worth $910,584,000.
- Accession
- 0001085146-17-000670
- Filer
- CIK 1544773
- Filed
- 2017-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2016
A holdings report, 23 entries on the cover page, a total value of $910,584,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $910,584,000 with VALUE read as thousands by filing date, 13F file number 028-14924. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| CLOVIS ONCOLOGY INC | 189464100 | COM | 2,730,887 | $121,306,000 | thousands by filing date | |
| HORIZON PHARMA PLC | G4617B105 | SHS | 5,793,903 | $93,745,000 | thousands by filing date | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 580,701 | $83,290,000 | thousands by filing date | |
| AMARIN CORP PLC | 023111206 | SPONS ADR NEW | 25,052,380 | $77,161,000 | thousands by filing date | |
| Mallinckrodt Plc | G5785G107 | SHS | 1,153,944 | $57,489,000 | thousands by filing date | |
| RETROPHIN INC | 761299106 | COM | 2,772,156 | $52,477,000 | thousands by filing date | |
| ATRICURE INC | 04963C209 | COM | 2,666,354 | $52,181,000 | thousands by filing date | |
| GLOBUS MED INC CL A | 379577208 | Stock | 1,860,000 | $46,165,000 | thousands by filing date | |
| ARIAD PHARMACEUTICALS INC | 04033A100 | COM | 3,553,943 | $44,211,000 | thousands by filing date | |
| PEDIATRIX MEDICAL GROUP INC | 58502B106 | COM | 660,000 | $43,996,000 | thousands by filing date | |
| MYRIAD GENETICS INC | 62855J104 | COM | 2,328,932 | $38,823,000 | thousands by filing date | |
| MERRIMACK PHARMACEUTICALS IN | 590328100 | COM | 9,067,998 | $36,997,000 | thousands by filing date | |
| AMAG PHARMACEUTICALS INC | 00163U106 | COM | 1,026,902 | $35,736,000 | thousands by filing date | |
| ANI PHARMACEUTICALS INC | 00182C103 | COM | 491,608 | $29,801,000 | thousands by filing date | |
| ARRAY BIOPHARMA INC COM | 04269X105 | Stock | 2,723,471 | $23,912,000 | thousands by filing date | |
| PACIRA BIOSCIENCES INC COM | 695127100 | Stock | 631,805 | $20,407,000 | thousands by filing date | |
| NOVADAQ TECHNOLOGIES INC COMMON | 66987G102 | COM | 2,413,179 | $17,109,000 | thousands by filing date | |
| ACADIA HEALTHCARE COMPANY INC COM | 00404A109 | Stock | 510,666 | $16,903,000 | thousands by filing date | |
| VERICEL CORP | 92346J108 | COM | 2,982,940 | $8,949,000 | thousands by filing date | |
| ADMA BIOLOGICS INC | 000899104 | COM | 1,273,933 | $6,523,000 | thousands by filing date | |
| BIOLASE INC | 090911108 | COMMON STOCK | 1,449,022 | $2,029,000 | thousands by filing date | |
| SEASPINE HLDGS CORP | 81255T108 | COM | 128,127 | $1,012,000 | thousands by filing date | |
| VERACYTE INC COM | 92337F107 | Stock | 46,752 | $362,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001085146-17-000670 | this filing | 2017-02-14 | acceptance time not in the bulk data set |